A 2022 meta-analysis from Mas Serrano et al found prior treatment with ACE inhibitors, diabetes, dyslipidemia, female gender, and hypertension to be associated with development of angioedema after alteplase administration.12 The gene discussed is ACE; the disease is angioedema.